Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$1.4B
Market Cap • 26/04/20242013
(há 11 anos)
2016
(8 years ago)
NASDAQ
Listagem
Waltham
Sede • MassachusettsValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
SYRESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.